Update Pharma's Unattributed Round

Update Pharma raised a round of funding on October 08, 2015.

Update Pharma is a clinical-stage small molecule company focused on developing overlooked or underutilized anti-cancer drugs. The company's lead compound, UPI-928 is a compound originally developed mo…

Articles about Update Pharma's Unattributed Round: